Mass Spectrometry Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||391377|
|出版日期||內容資訊||英文 113 Pages
|質譜分析的全球市場:成長，趨勢及預測(2017年∼2022年) Mass Spectrometry Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年04月01日||內容資訊: 英文 113 Pages||
The mass spectrometry market is expected witness a CAGR of 7.27% during the forecast period. Certain factors that are driving the market growth include the increasing technological advancement, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.
Mass spectrometry (MS) is one of the most powerful tools used for the analyses of a wide range of chemical and biological entities. In addition, the high demand and resulting requirements from the pharmaceutical and biotechnology industries are the main driving factors for some extraordinary recent advances in mass spectrometry technology. The advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools and software has the potential to stimulate the usage of mass spectroscopy across drugs development, proteomics, pharmaceuticals, food safety testing, and many other fields. The demands of the life sciences applications have led to the improvement of MS technologies and the rapid growth of new types of instruments. New mass spectrometry methods, collectively known as data independent analysis and hyper reaction monitoring, have recently emerged. Understanding complexity related to cancer biology requires extensive information about the cancer proteome over the course of the disease. Hence, with the increasing technological advancement, the market is expected to grow.
As per the scope of this report, mass spectrometry (MS) is an analytical chemistry technique used to identify the amount and type of chemical species present in a sample, by measuring the mass-to-charge ratio and abundance of gas phase ions.
Triple Quadrupole (Tandem) is Expected to Hold Significant Market Share in the Type of Hybrid Mass Spectrometry
Tandem mass spectrometry devices are currently among the most in demand. Conventional hospital diagnostic assays are based on clinical chemistry and immunoassay techniques that require analyte specific reagents and antibodies. LC-MS/MS-based approaches are considered reagent-free. The high specificity and sensitivity of LC-MS/MS overcome many limitations associated with the traditional immunoassays, such as non-specific antibody binding and cross-reactivity. There is a higher demand for hybrid instruments, such as triple quadrupole mass spectrometer, quadrupole time-of-flight mass spectrometer, etc. Currently, triple quadrupole MS is considered one of the most high-end instruments and many labs across the world are adopting this instrument.
North America Dominates the Market and Expected to do the Same in the Forecast Period
According to the Industrial Research Institute (IRI) report, the United States spends the world's highest (i.e., USD 516 billion) amount for research and development, currently. The United States spends 43% of the total life sciences/healthcare research and development and 56% of pharmaceutical/biotech R&D spending worldwide. Research and development include drug development and fundamental science research. Drug development, from the initial discovery to the final medication, is an expensive and lengthy process, and the failure rate is also high. High cost, lengthy time period, and the high failure rate are forcing researchers and drug manufacturing companies to look for newer technology, which can improve the process and reduce the cost at the same time. Mass spectrometry has the potential to do the same. It makes a functional and structural study, which takes a significant amount of time and resource in drug development, for the molecule, easier and faster.
The mass spectrometry market is highly competitive and consists of a few major players. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Dani instruments s.p.a, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold the substantial market share in the mass spectrometry market.